|
 Prof. Dr. Dr. Gunter Festel
has various university degrees in natural & social sciences including a PhD in chemistry and a PhD in economics. After a professional career with Bayer, Arthur D. Little and McKinsey he founded his own investment company FESTEL CAPITAL and has (co-) founded 15 biotechnology companies. Furthermore, he is professor for High-Tech and Life Science Venturing at the Technische Universität Berlin.
 Dr. Tim Friedrichson
holds degrees in biochemistry and cell biology. After his PhD he held different positions within a start-up biotech company and worked for the Max-Planck- Society. He focuses on the translational aspects of R&D, product development and business management.
 Dr. Wolfgang Sipos
studied chemistry and microbiology in Heidelberg. He was head of the purchasing department of Boehringer Mannheim/Roche Diagnostics before founding several companies and joining AppliChem GmbH. Together with his partners he sold the company successfully to ITW at the beginning of 2012. Since then he has invested in several start-ups helping them with regard to sourcing and business development.
 Dr. Joachim Venus
holds a diploma in Biotechnology and a PhD in Bioengineering. He is senior scientist “Industrial Biotechnology” and employed at the Dept. Bioengineering of ATB Potsdam as programme coordinator for the research programme “Material and energetic use of biomass” and is head of the research group bio-based products. His scientific focus is on the development of continuous processes for the production of basic chemicals - in particular lactic acid - from biogenic resources.
 Dr. Michael Baumann
holds a degree in chemistry and a PhD in medicinial chemistry. After his PhD he was a postdoctoral associate at the Massachusetts Institute of Technology (financed by IONIS Pharmaceuticals, Inc. in Cambridge/MA, USA) where his focus was on antibiotics research. Since 2002, he has held various positions and functions at Sanofi in the area of biopharmaceuticals.
|
